Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1993 1
1994 1
1997 1
1999 1
2005 1
2007 3
2008 1
2012 2
2013 2
2014 1
2018 2
2020 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Immunomodulation and lymphoma in humans.
Ponce RA, Gelzleichter T, Haggerty HG, Heidel S, Holdren MS, Lebrec H, Mellon RD, Pallardy M. Ponce RA, et al. Among authors: haggerty hg. J Immunotoxicol. 2014 Jan-Mar;11(1):1-12. doi: 10.3109/1547691X.2013.798388. Epub 2013 Jun 7. J Immunotoxicol. 2014. PMID: 23746314 Review.
BR96 sFv-PE40 immunotoxin: nonclinical safety assessment.
Haggerty HG, Warner WA, Comereski CR, Peden WM, Mezza LE, Damle BD, Siegall CB, Davidson TJ. Haggerty HG, et al. Toxicol Pathol. 1999 Jan-Feb;27(1):87-94. doi: 10.1177/019262339902700116. Toxicol Pathol. 1999. PMID: 10367679 Review.
Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations.
Gould JC, Carvajal I, Davidson T, Graham J, Hillegass J, Julien S, Kozhich A, Wang B, Wei H, Yamniuk AP, Mathias N, Haggerty HG, Graziano M. Gould JC, et al. Among authors: haggerty hg. Regul Toxicol Pharmacol. 2018 Dec;100:35-44. doi: 10.1016/j.yrtph.2018.10.003. Epub 2018 Oct 3. Regul Toxicol Pharmacol. 2018. PMID: 30291877
20 results